Spandana Sphoorty Financial Submits Q3FY26 Monitoring Agency Report for Rights Issue Proceeds
Spandana Sphoorty Financial Limited filed its Q3FY26 monitoring agency report showing complete utilization of Rs. 199.35 crore rights issue proceeds. CARE Ratings reported no deviations from stated objectives, with Rs. 195.02 crore used for capital augmentation and Rs. 4.33 crore for issue expenses. The company redirected Rs. 5.02 crore from general corporate purposes to the primary objective, while noting operational recovery despite ongoing sector challenges.

*this image is generated using AI for illustrative purposes only.
Spandana Sphoorty Financial Limited has filed its monitoring agency report for the quarter ended December 31, 2025, with BSE and NSE. The report, prepared by CARE Ratings Limited, provides details on the utilization of proceeds from the company's rights issue under SEBI regulations.
Rights Issue Details and Proceeds Utilization
The company's rights issue was structured for Rs. 400 crore with an issue period from August 01, 2025 to March 31, 2027. However, the company actually received Rs. 199.35 crore, representing 50% of the total issue size, due to rejection of some invalid applications submitted by applicants.
| Parameter | Amount (Rs. Crore) |
|---|---|
| Total Issue Size | 400.00 |
| Amount Actually Received | 199.35 |
| Amount Utilized by Quarter End | 199.35 |
| Unutilized Amount | 0.00 |
Object-wise Fund Deployment
The monitoring report reveals complete utilization of the received proceeds across the stated objectives:
| Objective | Proposed Amount (Rs. Crore) | Amount Utilized (Rs. Crore) | Status |
|---|---|---|---|
| Capital Base Augmentation | 380.00 | 195.02 | Fully Utilized |
| General Corporate Purposes | 15.64 | 0.00 | Redirected to Object 1 |
| Issue Related Expenses | 4.36 | 4.33 | Nearly Complete |
During Q3FY26, the company utilized Rs. 3.18 crore towards issue expenses, bringing total issue expense utilization to Rs. 4.33 crore against the estimated Rs. 4.36 crore. Notably, no amount was utilized during the quarter for the primary objective of capital base augmentation, as the company had already deployed Rs. 195.02 crore in previous quarters.
Monitoring Agency Assessment
CARE Ratings Limited reported no material deviations from the objectives stated in the offer document. The monitoring agency noted that Rs. 5.02 crore originally allocated for general corporate purposes was utilized towards the primary objective of augmenting capital base and meeting funding requirements.
The report highlighted that the company has been facing operational challenges, including:
- Significant decline in scale and deterioration in asset quality
- Reporting losses since Q2FY24 due to microfinance sector stress
- Breach of financial covenants affecting Rs. 306 crore of outstanding borrowings
- Waiver obtained for Rs. 219 crore of debt as of September 30, 2025
Company's Recovery Outlook
Despite the challenges, the company's Board of Directors noted improvement beginning in Q2FY26 that strengthened further in Q3FY26. The recovery is attributed to rising disbursement volumes and renewed borrower engagement, with collection efficiency in current buckets showing steady improvement. Loans originated in FY26 comprise 58% of the portfolio and demonstrate strong collection performance.
Regulatory Compliance
The monitoring report was submitted in compliance with Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Regulation 82(2) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report has been made available on the company's website at www.spandanasphoorty.com .
Historical Stock Returns for Spandana Sphoorty Financial
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.38% | -1.19% | -12.65% | -18.68% | -26.93% | -66.40% |


































